- Laboratory >
- Immunology >
- Cardiovascular disease test kit >
- PHC Europe
PHC Europe cardiovascular disease test kits
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Result display time: 17 min
Sample volume: 0.1 ml
PATHFAST™ determines the quantity of hs Trop I, NTproBNP, D-Dimer, hsCRP, Myoglobin and CK-MB mass from one single whole blood sample. The quantitative data of the parallel analyses provide results within minutes, which facilitate the ...
PHC Europe B.V. / PHCbi
Result display time: 17 min
Sample volume: 0.1 ml
PATHFAST™ determines the quantity of hs Trop I, NTproBNP, D-Dimer, hsCRP, Myoglobin and CK-MB mass from one single whole blood sample. The quantitative data of the parallel analyses provide results within minutes, which facilitate the ...
PHC Europe B.V. / PHCbi
Result display time: 17 min
Sample volume: 0.1 ml
... troponin (hs-cTnI) assays which meet the criteria defined by IFCC and ESC. PATHFAST™ provides high accuracy and precision of test results similar to central lab analyser, combined with the flexibility of a POCT assay ...
PHC Europe B.V. / PHCbi
Result display time: 17 min
Sample volume: 0.1 ml
... associated diseases. The PATHFAST™ hsCRP is an assay for measurement of CRP – also at low concentrations - in the format of a chemiluminescent enzyme immunoassay (CLEIA). All required components for performing the testing ...
PHC Europe B.V. / PHCbi
Result display time: 17 min
Sample volume: 0.1 ml
... a rapid and sensitive test in the early phase of AMI for its diagnosis in conjunction with the ECG and for exclusion of myocardial infarction in patients presenting with acute chest pain, especially after a further negative ...
PHC Europe B.V. / PHCbi
Result display time: 17 min
Sample volume: 0.1 ml
... long-term outcome presenting in the emergency department with and without cardiovascular impairment. NTproBNP also identifies subjects with rheumatoid disease who are at risk for cardiovascular ...
PHC Europe B.V. / PHCbi
Your suggestions for improvement:
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining